Robert Coleman, MBBS, MD, FRCP, FRCPE of Sheffield Cancer Research, University of Sheffield, UK discusses next steps for drug re-purposing, including keeping the topic in media and discussions with national health organisations like NICE, or MHRA. In addition, Dr Coleman highlights the power of patients, who can lobby and influence the regulatory situation of re-purposed drugs. Recorded at the 2016 National Cancer Research Institute (NCRI) Conference in Liverpool, UK.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest oncology news and updates